Delivery Order SPE2DB22D3501-SPE2DB25FWN76
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,911.53 to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets (60-count units) on July 25, 2025, with completion targeted for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,055.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Posaconazole 300 mg/16.7 ml vials. The contract, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. This award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 mL suspension (105 mL) valued at $9,864.11 on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical delivery under the DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Posaconazole 200 mg/5 mL suspension (105 mL) with a ceiling value of $3,727.32. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 24, 2025. The award was issued on July 23, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- This federal contract award, valued at $1,254.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of POSACONAZOLE DR 100 MG, a prescription medication, with a performance period extending until April 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- The Defense Logistics Agency awarded a $17,684.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 100mg posaconazole tablets. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for antifungal medication supports the DLA's mission to provide logistical support for the nation's armed forces. No...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, awarded without set-aside provisions through competitive procurement, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contractor will perform the work at its corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $44,769.20 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's broader indefinite delivery vehicle with the Defense Logistics Agency. The work will be performed at the contractor's corporate office location in...